Global Alcohol Dependency Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Alcohol Dependency Treatment Market Research Report 2024
According to Mr Accuracy reports’s new survey, global Alcohol Dependency Treatment market is projected to reach US$ 1432.6 million in 2034, increasing from US$ 538 million in 2024, with the CAGR of 15.0% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alcohol Dependency Treatment market research.
The key manufacturers of alcohol dependency treatment in the world include Alkermes Inc, Merck Group, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals and TAGI Pharma Inc., among which the top five manufacturers account for nearly 75% of the market share. The largest manufacturer is Alkermes Inc., which has more than 40% market share. The global alcohol dependency treatment market is mainly distributed in North America, Central Europe and Western Europe, Asia-Pacific region and Northern Europe, among which the first two markets account for more than 70% of the market share. At present, North America is the largest market, accounting for more than 45% of the market share, followed by Central Europe and Western Europe. As far as products are concerned, the relative growth rate of naltrexone is faster, with more than 60% of the market share at present, followed by acamprosate. In terms of application, hospital is the largest application field, accounting for more than 30% of the market share, followed by rehabilitation institutions and clinics.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alcohol Dependency Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Alkermes Inc
Merck Group
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd
Segment by Type
Naltrexone
Acamprosate
Disulfiram
Other
Hospital
Rehabilitation Institutions
Clinic
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alcohol Dependency Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
The key manufacturers of alcohol dependency treatment in the world include Alkermes Inc, Merck Group, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals and TAGI Pharma Inc., among which the top five manufacturers account for nearly 75% of the market share. The largest manufacturer is Alkermes Inc., which has more than 40% market share. The global alcohol dependency treatment market is mainly distributed in North America, Central Europe and Western Europe, Asia-Pacific region and Northern Europe, among which the first two markets account for more than 70% of the market share. At present, North America is the largest market, accounting for more than 45% of the market share, followed by Central Europe and Western Europe. As far as products are concerned, the relative growth rate of naltrexone is faster, with more than 60% of the market share at present, followed by acamprosate. In terms of application, hospital is the largest application field, accounting for more than 30% of the market share, followed by rehabilitation institutions and clinics.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alcohol Dependency Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Alkermes Inc
Merck Group
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd
Segment by Type
Naltrexone
Acamprosate
Disulfiram
Other
Segment by Application
Hospital
Rehabilitation Institutions
Clinic
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alcohol Dependency Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
